Clinical trial
Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma
NCT00257816 · University of California, Irvine, Other · Completed
Key facts
| NCT number | NCT00257816 |
|---|---|
| Title | Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma |
| Official title | A Pilot Study of Weekly IV Topotecan and Cisplatin With Concurrent Pelvic Radiation in the Treatment of Stages IB2 - IVA Cervical Carcinoma |
| Lead sponsor | University of California, Irvine, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug |
| Interventions | Topotecan, Cisplatin |
| Enrollment | 12 |
| Start date | Jan 1, 2004 |
| Primary completion | Dec 17, 2007 |
| Completion | Dec 17, 2007 |
| First posted | Nov 23, 2005 |
| Last update posted | Feb 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: